Mounjaro and Zepbound are Lillys dual agonists that seem to surpass Novo Nordisks Ozempic and Wegovy in weight loss power
Hernandez combines evidence-based metabolic medicine with pediatric endocrinology, nutrition, exercise physiology, behavioral health, and personalized lifestyle interventions to help children build healthier metabolism and lifelong wellness
That said, the formula isn't limited to menopause
Even though most of these drugs do not cross the blood-brain barrier, brain fog is often one of the first symptoms affected and may be due to improvements in blood flows
Long-term safety and efficacy data are also essential
An important consideration is that, if people prefer a device, they may be more willing to use the medication, potentially resulting in improved health outcomes